首页> 外文期刊>Patient Preference and Adherence >Factors that influence patient preferences for prostate cancer management options: a systematic review
【24h】

Factors that influence patient preferences for prostate cancer management options: a systematic review

机译:影响患者对前列腺癌治疗选择的偏好的因素:系统评价

获取原文
           

摘要

Purpose: We performed a systematic review to evaluate evidence regarding factors that influence patient preferences for management options for localized prostate cancer.Methods: We followed a prespecified search protocol (PROSPERO identifier CRD42014009173) to identify studies that evaluated patient preferences for prostate cancer management options for localized prostate cancer. We queried PubMed, the Cochrane Database of Systematic Reviews, Embase, Cumulative Index to Nursing & Allied Health Literature (CINAHL) Plus, and Econ-Lit databases. Two separate reviewers completed the article selection process and review, including coding of study characteristics. Study quality was scored according to the PREFS checklist, which consists of five criteria: Purpose, Respondents, Explanation, Findings, and Significance. Reviewers summarized the primary findings of each article included in the analysis.Results: Of the 606 citations identified in the literature search, there were a total of 21 articles that met all selection criteria, reporting results for a total of 4,131 subjects. Themes identified in the studies included: the importance of patient perceptions of treatment efficacy and side effects; the influence of physician recommendations on patient decision-making; and the prioritization of concerns regarding treatment side effects among those men who prefer radiation therapy or active surveillance. The articles had an average PREFS score of 3.4 (standard deviation [SD] 1.0), which is similar to a recent study for breast cancer treatment preferences. Conclusion: This systematic review of factors that influence patient preferences for prostate cancer management options identified a small, but high quality, group of articles that satisfied the selection criteria. The available evidence suggests that interventions aimed at informing patients regarding the comparative effectiveness of prostate cancer management alternatives should include the influence of physician recommendations and family members’ desires on patient decision-making.
机译:目的:我们进行了系统的评估,以评估影响患者对局限性前列腺癌治疗选择的偏好的因素的证据。方法:我们遵循预先指定的搜索协议(PROSPERO标识符CRD42014009173)来鉴定评估患者对前列腺癌治疗选择的偏好的研究局限性前列腺癌。我们查询了PubMed,Cochrane系统评价数据库,embase,护理和相关健康文献累积索引(CINAHL)Plus和Econ-Lit数据库。两名独立的审稿人完成了文章选择过程和审稿,包括研究特征的编码。根据PREFS清单对研究质量进行评分,该清单由五个标准组成:目的,受访者,解释,发现和重要性。审稿人总结了分析中每篇文章的主要发现。结果:在文献检索中确定的606条引用中,共有21条符合所有选择标准的文章,总共报告了4131名受试者。研究确定的主题包括:患者对治疗功效和副作用的认识的重要性;医生建议对患者决策的影响;并优先考虑那些倾向于放射治疗或积极监测的男性对治疗副作用的关注。文章的平均PREFS评分为3.4(标准差[SD] 1.0),与最近针对乳腺癌治疗偏好的研究相似。结论:对影响患者对前列腺癌治疗选择的偏爱的因素的系统综述确定了满足选择标准的一小批高质量文章。现有证据表明,旨在告知患者前列腺癌治疗替代方案相对有效性的干预措施应包括医师建议和家庭成员对患者决策的渴望的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号